M...do you think perhaps a big pharma takeover candidate is guiding ATHE and instructing them what they need to do before they will pull the trigger on a take-out or partnership deal? Over 10 years ago, I felt that Eli Lilly was a prime candidate and that still remains a possibility today, IMO, with their recent renewed interest in pursuing the Alzheimer's holy grail. Fingers crossed...
Ann: New US patent targeting major neurodegenerative diseases, page-10
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.62M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $886 | 275.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 48 | 56368671 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 125986200 | 26 |
View Market Depth
| Last trade - 11.34am 30/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |